Clinical Trial for Zebinix (Eslicarbazepine Acetate) in Healthy Korean and Caucasian Adult

Clinical trial NCT04095182 · COMPLETED

Trial details

NCT number: NCT04095182
Sponsor: Whanin Pharmaceutical Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Partial-onset Seizures With or Without Secondary Generalisation

Start date: 2019-08-22
Primary completion: 2019-12-16
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.